U.S. equities extended their AI-fueled winning streak on Wednesday, May 6, with the major indices pushing deeper into record territory as chip stocks, easing oil ($95.63/bbl,-6.49%), and a budding “peace premium” outweighed lingering rate and inflation worries.
Indices and risk tone
The…
In a move that blurs the line between sports passion and paid profession, Fox Sports (FOX) has unveiled what may be the most enviable job listing of the year: $50,000 for one devoted fan willing to watch every single match of the…
Eupraxia’s (NASDAQ: EPRX) latest data drop puts eosinophilic esophagitis (EoE) firmly at center stage, with fresh endoscopic and long‑term clinical results suggesting EP‑104GI could emerge as a once‑yearly, procedure‑based alternative to chronic biologic regimens such as Sanofi’s (SNY) multi-billion dollar weekly-injectable drug…
Amwell’s (NYSE: AMWL) latest story is a quiet telehealth turnaround: a company that spent the last cycle building infrastructure now talking more about operating leverage, sticky SaaS, and a disciplined path to growth – all while the rest of digital health is…
US equities extended their record-setting run on Tuesday as mega-cap tech and AI beneficiaries pulled the tape higher again, even as oil backed off recent spikes and macro data painted a picture of solid but not spectacular growth heading into a heavy…
Defense Secretary Pete Hegseth faced an unexpected challenge at a Pentagon press briefing Tuesday: dismissing claims that Iran possesses "kamikaze dolphins" capable of suicide attacks in the Strait of Hormuz. The question, which emerged from Wall Street Journal reporting on Iranian officials…
Intel’s latest rally is more than just another chip stock pop; it’s the market’s way of voting “yes” on a reshuffled AI and manufacturing order in which Intel (INTC), Apple (AAPL), and Nvidia (NVDA) are quietly rehearsing for a new ensemble performance.…
The factory floor used to hum with human rhythm—coffee breaks, chatter, the occasional misplaced wrench. Today, it hums differently. Precision has replaced improvisation, algorithms have replaced instinct, and the newest employee doesn’t require healthcare or sleep.
Welcome to the robotics economy, where…
Amwell (AMWL, $6.42) is preparing to unveil its first quarter 2026 operating results on May 5, marking a critical checkpoint in the Boston-based telehealth platform's journey toward operational cash flow breakeven. Analysts anticipate revenue of approximately $51.5 million for the quarter, with…
US stocks opened the first full week of May on the back foot, with all three major indices closing lower Monday as investors digested big AI‑software earnings against a still higher‑for‑longer macro and rates backdrop. The tone was risk‑off rather than panicked:…
